SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-506560
Filing Date
2012-12-18
Accepted
2012-12-18 16:18:00
Documents
8
Period of Report
2012-12-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d456654d8k.htm 8-K 20570
2 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT WITH DANIEL SPIEGELMAN d456654dex101.htm EX-10.1 7034
3 AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT d456654dex102.htm EX-10.2 7045
4 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT WITH JEFFREY AJER d456654dex103.htm EX-10.3 7023
5 AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT WITH ROBERT A. BAFFI d456654dex104.htm EX-10.4 7163
6 AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT WITH HENRY J. FUCHS d456654dex105.htm EX-10.5 7135
7 AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT WITH G. ERIC DAVIS d456654dex106.htm EX-10.6 7118
8 AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT WITH MARK WOOD d456654dex107.htm EX-10.7 7098
  Complete submission text file 0001193125-12-506560.txt   71369
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 121271553
SIC: 2834 Pharmaceutical Preparations